Exogenous oestrogen exposure, female reproductive factors and the long-term incidence of cataract: The Blue Mountains Eye Study

Acta Ophthalmologica

Volumn 88, Issue 7, 2010, Pages 773-778

  Kanthan, Gowri L ^a   Wang, Jie Jin ^a,b   Burlutsky, George ^a   Rochtchina, Elena ^a   Cumming, Robert G ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

cataract; female reproductive factors; hormone replacement therapy; oestrogen; oral contraceptive pill; risk factors

Indexed keywords

ESTROGEN; STEROID;

ADULT; ARTICLE; CATARACT; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FEMALE GENITAL SYSTEM; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INCIDENCE; MENARCHE; ORAL CONTRACEPTION; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS;

AGE FACTORS; AGED; AUSTRALIA; CATARACT; COHORT STUDIES; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LENS CORTEX, CRYSTALLINE; MENARCHE; MENOPAUSE; MIDDLE AGED; SINGLE-BLIND METHOD;

EID: 78349282677     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01565.x     Document Type: Article

References (29)

1. Aina FO, Smeeth L, Hubbard R, Hurt LS, &, Fletcher AE, (2006): Hormone replacement therapy and cataract: a population-based case-control study. Eye 20: 417 - 422.
2. Attebo K, Mitchell P, &, Smith W, (1996): Visual acuity and the causes of visual loss in Australia. Ophthalmology 103: 357 - 364.
3. Bigsby RM, Cardenas H, Caperell-Grant A, &, Grubbs CJ, (1999): Protective effects of estrogen in a rat model of age-related cataracts. Proc Natl Acad Sci USA 96: 9328 - 9332.
4. Cumming RG, &, Mitchell P, (1997): Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 145: 242 - 249.
5. Davis VL, Chan CC, Schoen TJ, Couse JF, Chader GJ, &, Korach KS, (2002): An estrogen receptor repressor induces cataract formation in transgenic mice. Proc Natl Acad Sci USA 99: 9427 - 9432.
6. Defay R, Pinchinat S, Lumbroso S, Sultan C, Papoz L, &, Delcourt C, (2003): Relationships between hormonal status and cataract in French postmenopausal women: the POLA study. Ann Epidemiol 13: 638 - 644.
7. Freeman EE, Munoz B, Schein OD, &, West SK, (2004): Incidence and progression of lens opacities - effect of hormone replacement therapy and reproductive factors. Epidemiology 15: 451 - 457.
8. Hales AM, Chamberlain CG, Murphy CR, &, McAvoy JW, (1997): Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta). J Exp Med 185: 273 - 280.
9. Kanthan GL, Wang JJ, Rochtchina E, Tan AG, Lee A, Chia E, &, Mitchell P, (2008): Ten-year incidence of age-related cataract and cataract surgery in an older Australian population. The Blue Mountains Eye Study. Ophthalmology 115: 808 - 814.
10. Klein BEK, Klein R, Linton KLP, Magli YL, &, Neider MW, (1990): Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 97: 1428 - 1433.
11. Klein BE, Klein R, &, Ritter LL, (1994): Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 112: 85 - 91.
12. Klein BEK, Klein R, &, Lee KE, (2000): Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the Beaver Dam Eye Study. Am J Ophthalmol 130: 322 - 326.
13. Klein BEK, Klein R, &, Lee KE, (2002): Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. Ophthalmology 109: 2052 - 2057.
14. Landis JR, &, Koch GG, (1977): The measurement of observer agreement for categorical data. Biometrics 33: 159 - 174.
15. Leske MC, Wu SY, Nemesure B, Yang L, &, Hennis A, (2004): Nine-year incidence of lens opacities in the Barbados Eye Studies. Ophthalmology 111: 483 - 490. (Pubitemid 38293103)
16. Mitchell P, Smith W, Attebo K, &, Wang JJ, (1995): Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102: 1450 - 1460.
17. Mitchell P, Cumming RG, Attebo K, &, Panchapakesan J, (1997): Prevalence of cataract in Australia. Ophthalmology 104: 581 - 588.
18. Mooradian AD, (1993): Antioxidant properties of steroids. J steroid Biochem Mol Biol 45: 509 - 511.
19. Nirmalan PK, Katz J, Robin AL, Ramakrishnan R, Krishnadas R, Thulasiraj RD, &, Tielsch JM, (2004): Female reproductive factors and eye disease in a rural south Indian population: the Aravind comprehensive eye survey. Invest Ophthalmol Vis Sci 45: 4273 - 4276.
20. Ogueta SB, Schwartz SD, Yamashita CK, &, Farber DB, (1999): Estrogen receptor in the human eye: influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 40: 1906 - 1911.
21. Paganini-Hill A, &, Clark LJ, (2000): Eye problems in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 60: 167 - 172.
22. Panchapakesan J, Cumming R, &, Mitchell P, (1997): Reproducibility of the Wisconsin cataract grading system in the Blue Mountains Eye Study. Ophthalmic Epidemiol 4: 119 - 126. (Pubitemid 27453600)
23. Parkkari M, Paakkala AM, Salminen L, &, Holli K, (2003): Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up study. Acta Ophthalmol Scand 81: 495 - 499.
24. Rossouw JE, Anderson GL, Prentice RL, et al. (2002): Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321 - 333.
25. Steiner DL, &, Norman GR, (1989): Reliability, health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press.
26. Uncu G, Avci R, Uncu Y, Kaymaz C, &, Develioglu O, (2006): The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynaecol Endocrinol 22: 501 - 505.
27. Weintraub JM, Taylor A, Jacques P, Willet WC, Rosner B, Colditz GA, Chylack LT, &, Hankinson SE, (2001): Postmenopausal hormone use and lens opacities. Ophthalmic Epidemiol 9: 179 - 190.
28. Worzala K, Hiller R, Sperduto RD, Mutalik K, Murabito JM, Moskowitz M, D'agostino RB, &, Wilson PWF, (2001): Postmenopausal estrogen use, type of menopause, and lens opacities. the Framingham studies. Arch Ophthalmol 161: 1448 - 1454.
29. Younan C, Mitchell P, Cumming R, Panchapakesan J, Rochtchina E, &, Hales AM, (2002): Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery. Am J Epidemiol 155: 997 - 1006.